Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of LEO 29102 Cream in atopic dermatitis; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LEO 29102 Cream

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 1 | Status: TERMINATED